Ahluwalia, P <br/><br/>
Nedocromil sodium and levocabastine reduce the symptoms of conjunctival allergen challenge by different mechanisms.  [electronic resource] 

 -  The Journal of allergy and clinical immunology  Sep 2001 
 - 449-54 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0091-6749 
<br/><br/><label>Standard No.: </label>10.1067/mai.2001.117591  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-Allergic Agents--therapeutic use<br/>Conjunctiva--chemistry<br/>Conjunctivitis, Allergic--drug therapy<br/>E-Selectin--analysis<br/>Female<br/>Histamine--analysis<br/>Histamine H1 Antagonists--therapeutic use<br/>Humans<br/>Intercellular Adhesion Molecule-1--analysis<br/>Lolium--adverse effects<br/>Male<br/>Middle Aged<br/>Nedocromil--therapeutic use<br/>Piperidines--therapeutic use<br/>Prostaglandin D2--analysis<br/>Tears--chemistry<br/>Vascular Cell Adhesion Molecule-1--analysis